We Help Companies Find New Sales Opportunities
PPL Therapeutics is said to be planning to shed at least 90 jobs at its research facility in Roslin, after partner Bayer stopped a project to develop treatments for lung disorders.
PPL Therapeutics has dropped plans to build a £42m biotechnology plant near Edinburgh, and may now outsource its manufacturing operations.
PPL Therapeutics is to sell its xenograft and stem cell activities to a newly-formed US company called Regenecor Holdings, in which PPL will hold an equity stake.
PPL Therapeutics is looking to raise about £20m in a share issue to fund the development of its new drug manufacturing facilities.
PPL Therapeutics has confirmed plans to build a £42m bio-manufacturing facility at the Gowkley Moss Farm site near Penicuik, Midlothian, where it will employ up to 250 people.
PPL Therapeutics has announced plans to build a £42m drug manufacturing plant in Scotland with the creation of 150 jobs, and is seeking a suitable site in the Lothians.